Biotech

All Articles

Former Seagen chief executive officer reveals brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer in 2015 for a mas...

Ironwood creates further bid for $1B GI drug along with new subgroup records

.On the heels of a phase 3 succeed that fell short to impress real estate investors, Ironwood Pharma...

Novartis inks $150M offer for autoimmune molecular glue

.Do not stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...

Jade carves out officer group with Chinook vets-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable management hirings, firings ...

Septerna goes public along with upsized offering of $288M

.Celebrating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called ...

AbbVie creates Richter richer, paying $25M to form breakthrough pact

.AbbVie has gone back to the resource of its antipsychotic giant Vraylar looking for an additional s...

GenSight goes into ultimate weeks of cash runway as profits stream edges out of reach

.GenSight Biologics is weeks far from losing money. Again. The biotech merely has sufficient money t...

AZ licenses thrown away uncommon illness medicine to Monopar Therapeutics

.Monopar Therapeutics is bouncing back a drug coming from the scrap heap of AstraZeneca's rare illne...

Arcus' brand new HIF-2a data in renal cancer cells mean potential upper hand over Merck's Welireg, professionals state

.Along with brand new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of anal...

Roche wagers approximately $1B to grow Dyno gene treatment shipping treaty

.After developing a gene therapy relationship with Dyno Therapies in 2020, Roche is back for even mo...